跳至主要内容
临床试验/ISRCTN30952488
ISRCTN30952488已完成4 期

A series of randomised controlled N-of 1 trials in patients who have discontinued or are considering discontinuing statin use due to muscle-related symptoms to assess if atorvastatin treatment causes more muscle symptoms than placebo.

ondon School of Hygiene and Tropical Medicine0 个研究点目标入组 200 人开始时间: 2016年5月12日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

2017 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/29197834 protocol 2021 Results article in https://doi.org/10.1136/bmj.n135 results (added 25/02/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33709907/ results (added 15/03/2021) 2019 Results article in https://doi.org/10.3390/healthcare7040134 (added 14/06/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adults (aged 16 and over)
  • 2. Prescribed statin treatment in the last 3 years
  • 3. Stopped OR considering stopping statin treatment due to muscle symptoms
  • 4. Provided fully informed consent

排除标准

  • 1. Any previously documented serum alanine aminotransferase (ALT) levels at or above three times the upper limit of normal
  • 2. Have persistent, generalised, unexplained muscle pain (whether associated or not with statin use) and have creatinine kinase (CK) levels greater than 5 times the upper limit of normal
  • 3. Should not be using atorvastatin 20mg daily in the opinion of the general practitioner

研究者

发起方
ondon School of Hygiene and Tropical Medicine

相似试验